Silent Endometriosis and Its Impact on Reproductive Health
Endometriosis affects women worldwide, yet it takes an average of 7 to 10 years to receive a diagnosis. Silent endometriosis involves a form of the disease in which tissue similar to the uterine lining grows outside the uterus without producing the obvious pelvic pain. Because the hallmark symptom is absent, silent endometriosis frequently goes undetected until it has already interfered with fertility or caused other reproductive complications. At MyReceptiva, we provide a test that helps detect endometriosis and provides answers for unexplained infertility. Here’s how silent endometriosis impacts reproductive health:
The Biology of Silent Endometriosis
Endometriosis occurs when tissue from the endometrial lining of the uterus grows on the ovaries. It also appears on the fallopian tubes or the outer wall of the uterus, the intestines, and other abdominal organs. In symptomatic cases, pain may occur in the pelvis as well as other areas of the body. In asymptomatic cases, silent endometriosis follows the same biological process, with abnormal tissue growth, inflammation, and immune dysregulation; it occurs without generating pain.
The protein marker BCL6 helps explain why the disease can be active even without symptoms. BCL6 affects cell growth, survival, inflammation, and immune response; it is expressed at elevated levels in the uterine lining, including in women with no symptoms. Women without endometriosis generally do not exhibit elevated BCL6 expression in the endometrium. This suggests that inflammation associated with endometriosis can be detected at the cellular level before pain develops.
The Effect on Fertility
For women with silent endometriosis, infertility or recurrent pregnancy loss may be the first indication of the disease. Endometriosis contributes to unexplained infertility and unexplained recurrent pregnancy loss through many of the same underlying biological mechanisms. Women with elevated BCL6 expression and suspected endometriosis experience poorer outcomes following embryo transfer, including higher miscarriage rates and lower clinical pregnancy and live birth rates, compared with women who receive pre-treatment before embryo transfer.
The Diagnostic Delays Women Face
65% of women with endometriosis are misdiagnosed, and 46% see more than five physicians before receiving an accurate diagnosis. Silent endometriosis compounds this problem because the absence of pain removes the signal for clinical investigation. When women do present with infertility or pregnancy loss, endometriosis may not be the first condition a provider reviews if the patient reports no history of pain.
Laparoscopic surgery helps diagnose endometriosis because it allows direct visual confirmation. The surgery involves invasive processes and is not accessible to all patients. Imaging technologies, such as ultrasound, also have limitations in detecting all forms of the disease. Women without classic symptoms often cycle through multiple providers over the course of several years without receiving a diagnosis that explains their reproductive difficulties.
The MyReceptiva Test
The MyReceptiva test provides a non-surgical detection option for women who may have endometriosis. The test identifies the BCL6 protein marker through a timed endometrial biopsy collected 7 to 10 days after ovulation, during a routine office visit. A positive BCL6 result carries a greater probability that endometriosis is present. A negative result indicates less than a 7% chance that endometriosis will be found surgically. The test has been independently verified by multiple laparoscopic surgery centers for subsequent surgical findings of endometriosis or other inflammatory conditions.
Get the Testing You Need Today
Silent endometriosis demonstrates that the absence of pain does not indicate the absence of disease. Infertility, recurrent miscarriage, and IVF failure are documented outcomes of endometriosis even when pelvic pain is not part of the clinical picture. Early detection allows for treatment before additional reproductive complications develop. A MyReceptiva test helps determine whether women carry regular endometriosis or the silent form. Contact our team today to learn more about the test and its timeline.
